Showing results (1741-1750 of 4,314) with videos related to

Sort By:
Pageof 432
ACS Applied Materials & Interfaces|October 15, 2020
Hysteresis and Instability Predicted in Moisture Degradation of Perovskite Solar CellsKelvin J Xu, Ryan T Wang, Alex F Xu, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|February 15, 2008
Hierarchical spatial hashing-based collision detection and hybrid collision response in a haptic surgery simulatorX Li, L Gu, S Zhang, et al.
British Journal of Cancer|March 13, 2014
Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancerH He, Z Shen, H Zhang, et al.
Applied Optics|March 22, 2008
Temporal evolution of beam fanning in LiNbO(3):Fe, In crystalsX Zhang, J Xu, S Liu, et al.
The Journal of Nutrition, Health & Aging|February 14, 2014
Calcitonin receptor gene polymorphism in cCinese Xinjiang Han and Uygur women with primary osteoporosisJ Xu, Y Gao, J Yin, et al.
Genetics and Molecular Research : GMR|October 6, 2016
Assessment of genetic relationship among Rhododendron cultivars using amplified fragment length polymorphism and inter-simple sequence repeat markersJ J Xu, B Zhao, H F Shen, et al.
Chemical Society Reviews|April 13, 2019
Approaches for measuring the surface areas of metal oxide electrocatalysts for determining their intrinsic electrocatalytic activityChao Wei, Shengnan Sun, Daniel Mandler, et al.
Experimental Dermatology|March 18, 2023
Baseline clinical, hormonal and molecular markers associated with clinical response to IL-23 antagonism in hidradenitis suppurativa: A prospective cohort studyA Flora, E K Kozera, R Jepsen, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|November 6, 2024
[MiR-6838-5p overexpression inhibits proliferation of breast cancer MCF-7 cells by downregulating DDR1 expression]L Xue, Q Tan, J Xu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 3, 2023
Safety and feasibility of CDK4/6 inhibitors treatment combined with radiotherapy in patients with HR-positive/HER2-negative breast cancer. A systematic review and meta-analysisMarcin Kubeczko, Michał Jarząb, Dorota Gabryś, et al.
Pageof 432